Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher OpenFDA by Year
openFDA — MAUDE Adverse Event Reports for the Danaher Ecosystem
Danaher OpenFDA: 1,243 in FY2025, up 12.7% from a year earlier.
Latest, FY2025
1,243
Period ended Dec 31, 2025
Change on a year earlier
+12.7%
1,103 in FY2024
History
11 years
Since FY2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)
Where the FY2025 figure comes from
Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Reported in U.S. FDA openFDA MAUDE Adverse Event API.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up openFDA
- Beckman Coulter (Diagnostics & Life Sciences) — MAUDE Adverse Event Reports745 · FY2025
- Cepheid (GeneXpert Molecular Diagnostics) — MAUDE Adverse Event Reports43 · FY2025
- Radiometer Medical (Blood Gas & Acute Care Analyzers) — MAUDE Adverse Event Reports147 · FY2025
- Leica Biosystems & Microsystems (Pathology & Microscopy) — MAUDE Adverse Event Reports83 · FY2025
- HemoCue (Point-of-Care POC Hematology Testing) — MAUDE Adverse Event Reports0 · FY2025
- Devicor Medical / Mammotome (Breast Biopsy & Cancer Diagnostics) — MAUDE Adverse Event Reports32 · FY2025
- Masimo Corporation (Pulse Oximetry & Non-Invasive Patient Monitoring) — MAUDE Adverse Event Reports193 · FY2025
Cite this data
StockData. (2026). Danaher OpenFDA, annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-maude-dhr-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.